These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23875763)

  • 1. Hepatotoxicity: a scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action.
    Hewitt M; Enoch SJ; Madden JC; Przybylak KR; Cronin MT
    Crit Rev Toxicol; 2013 Aug; 43(7):537-58. PubMed ID: 23875763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An expert system approach to the assessment of hepatotoxic potential.
    Marchant CA; Fisk L; Note RR; Patel ML; Suárez D
    Chem Biodivers; 2009 Nov; 6(11):2107-14. PubMed ID: 19937847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the use of in silico methods to predict the chemistry of molecular initiating events related to drug toxicity.
    Ellison CM; Enoch SJ; Cronin MT
    Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1481-95. PubMed ID: 22032332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.
    Zhu X; Kruhlak NL
    Toxicology; 2014 Jul; 321():62-72. PubMed ID: 24721472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying mechanisms of chemical toxicity to predict drug safety.
    Guengerich FP; MacDonald JS
    Chem Res Toxicol; 2007 Mar; 20(3):344-69. PubMed ID: 17302443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward predictive models for drug-induced liver injury in humans: are we there yet?
    Chen M; Bisgin H; Tong L; Hong H; Fang H; Borlak J; Tong W
    Biomark Med; 2014; 8(2):201-13. PubMed ID: 24521015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting toxicities of reactive metabolite-positive drug candidates.
    Kalgutkar AS; Dalvie D
    Annu Rev Pharmacol Toxicol; 2015; 55():35-54. PubMed ID: 25292426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages.
    Giri S; Nieber K; Bader A
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):895-917. PubMed ID: 20367107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-Driven Read-Across of Chemical Hepatotoxicants Based on Chemical Structures and Biological Data.
    Zhao L; Russo DP; Wang W; Aleksunes LM; Zhu H
    Toxicol Sci; 2020 Apr; 174(2):178-188. PubMed ID: 32073637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing structure-activity relationships for the prediction of hepatotoxicity.
    Greene N; Fisk L; Naven RT; Note RR; Patel ML; Pelletier DJ
    Chem Res Toxicol; 2010 Jul; 23(7):1215-22. PubMed ID: 20553011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury.
    Chen M; Borlak J; Tong W
    Hepatology; 2013 Jul; 58(1):388-96. PubMed ID: 23258593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
    Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
    Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying chemicals based on receptor binding/bioactivation/mechanistic explanation associated with potential to elicit hepatotoxicity and to support structure activity relationship-based read-across.
    Wu S; Daston G; Rose J; Blackburn K; Fisher J; Reis A; Selman B; Naciff J
    Curr Res Toxicol; 2023; 5():100108. PubMed ID: 37363741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-driven modeling of chemical hepatotoxicity using structural alerts and an in vitro screening assay.
    Jia X; Wen X; Russo DP; Aleksunes LM; Zhu H
    J Hazard Mater; 2022 Aug; 436():129193. PubMed ID: 35739723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of hepatocytes to investigate drug toxicity.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Methods Mol Biol; 2010; 640():389-415. PubMed ID: 20645064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxic constituents and toxicological mechanism of Xanthium strumarium L. fruits.
    Xue LM; Zhang QY; Han P; Jiang YP; Yan RD; Wang Y; Rahman K; Jia M; Han T; Qin LP
    J Ethnopharmacol; 2014 Mar; 152(2):272-82. PubMed ID: 24447814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation in drug-induced liver injury.
    Leung L; Kalgutkar AS; Obach RS
    Drug Metab Rev; 2012 Feb; 44(1):18-33. PubMed ID: 21939431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of organ toxicity endpoints by QSAR modeling based on precise chemical-histopathology annotations.
    Myshkin E; Brennan R; Khasanova T; Sitnik T; Serebriyskaya T; Litvinova E; Guryanov A; Nikolsky Y; Nikolskaya T; Bureeva S
    Chem Biol Drug Des; 2012 Sep; 80(3):406-16. PubMed ID: 22583392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics in the search for mechanisms and biomarkers of drug-induced hepatotoxicity.
    Van Summeren A; Renes J; van Delft JH; Kleinjans JC; Mariman EC
    Toxicol In Vitro; 2012 Apr; 26(3):373-85. PubMed ID: 22274661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA; Yang Y; Waring JF
    Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.